CGON
CG Oncology, Inc.
$26.82
+$0.11(+0.39%)
36
Overall
--
Value
36
Tech
36
Quality
Market Cap
$2.06B
Volume
400.02K
52W Range
$14.80 - $40.47
Target Price
$56.55
Order:
Income Statement
| Metric | Trend | Chart | 2024 Dec |
|---|---|---|---|
| REVENUE | |||
| Total Revenue | $1.1M | ||
| Total Revenue | $1.1M | ||
| GROSS PROFIT | |||
| Gross Profit | $1.1M | ||
| OPERATING EXPENSES | |||
| Operating Expenses | $115.8M | ||
| Research & Development | $82.1M | ||
| Research Expense | $82.1M | ||
| Selling, General & Administrative | $33.7M | ||
| General & Administrative Expenses | $33.7M | ||
| Salaries & Wages | $11.4M | ||
| Other Operating Expenses | $-409.0K | ||
| OPERATING INCOME | |||
| Operating income | $-114.7M | ||
| EBITDA | $-88.0M | ||
| NON-OPERATING ITEMS | |||
| Intinc | $26.6M | ||
| Net Non-Operating Interest Income/Expense | $26.6M | ||
| Other Income/Expense | $-3.0K | ||
| Other Special Charges | $3.0K | ||
| PRE-TAX INCOME | |||
| EBIT | $-88.0M | ||
| Pre-Tax Income | $-88.0M | ||
| NET INCOME | |||
| Net Income | $-88.0M | ||
| Net Income (Continuing Operations) | $-88.0M | ||
| Net Income (Discontinued Operations) | $-88.0M | ||
| Net Income (Common Stockholders) | $-88.0M | ||
| Normalized Income | $-87.2M | ||
| TOTALS | |||
| Total Expenses | $115.8M | ||
| SHARE & EPS DATA | |||
| Average Shares Outstanding | $62.5M | ||
| Average Shares Outstanding (Diluted) | $62.5M | ||
| Shares Outstanding | $76.2M | ||
| Basic EPS | $-1.41 | ||
| Basic EPS (Continuing Operations) | $-1.41 | ||
| Diluted EPS | $-1.41 | ||
| Diluted EPS (Continuing Operations) | $-1.41 | ||
| OTHER METRICS | |||
| Other Gand A | $33.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGON | $26.82 | +0.4% | 400.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |